Form 4: Oscar Health CTO Sells Shares for Tax Obligations
Insider Transaction Report
Oscar Health's President of Technology & CTO, Mario Schlosser, sold 23,965 shares of Class A Common Stock to cover tax withholding obligations.
Summary
- Mario Schlosser, Oscar Health, Inc.'s President of Technology & CTO and a Director, reported a sale of company stock.
- The transaction involved the disposition of 23,965 shares of Class A Common Stock.
- The shares were sold on December 2, 2025, at a weighted average price of $16.59 per share.
- The sale was executed pursuant to a Rule 10b5-1 instruction letter established on August 8, 2025.
- The purpose of the sale was to satisfy tax withholding obligations arising from the vesting of previously granted equity awards.
- Following this transaction, Mario Schlosser beneficially owns 477,183 shares of Class A Common Stock directly.
Sentiment
Score: 5
Explanation: The transaction is a routine, pre-planned sale by an insider to cover tax obligations upon equity award vesting, which is a neutral event and does not reflect a change in company fundamentals or executive sentiment.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This filing is a routine insider transaction report and does not provide information directly related to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: The sale is a routine tax-related transaction and is unlikely to have a significant impact on shareholder perception or the company's valuation.
Key Dates
| Date | Description |
|---|---|
| 08/08/2025 | Date Rule 10b5-1 instruction letter was entered into for the sale of equity securities. |
| 12/02/2025 | Date of the reported transaction (sale of Class A Common Stock). |
| 12/04/2025 | Date the Form 4 filing was signed. |
Recommendation
holdThe filing details a routine insider sale by a company executive to cover tax obligations upon the vesting of equity awards, executed under a pre-arranged 10b5-1 plan. This type of transaction is common and generally does not indicate a change in the executive's confidence in the company or warrant a shift in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this event does not alter the fundamental investment thesis.
Keywords
Oscar Health, OSCR, Insider Trading, Stock Sale, Executive Compensation, Tax Withholding, Mario Schlosser, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.